Located in Santa Fe, a major business district in Mexico City, the new office will support local operations and enhance collaboration with partners. This opening advances the company’s expansion in Mexico and demonstrates its commitment to growth throughout Latin America. On 3 June 2026, Farmak International celebrated the official inauguration of its Mexico City office together with company leaders, local colleagues, and partners. The occasion was marked by a ribbon-cutting ceremony with Viktor Kostiuk, CEO and President of the Board of Farmak International; Roberto Asensio, Chief Business Development Officer; Marcel Pujol, Chief People & Culture Officer; Xavier Luzuriaga, Country Head of Mexico; and Taras Yakovenko, Global Portfolio Director. Farmak Group's medicines have been available in Mexico since 2020, establishing a foundation for the company’s continued growth. The portfolio covers ophthalmology, anaesthesiology, systemic hormonal preparations, antithrombotic therapy, and metabolism-related and supportive care. With a permanent local team in place, Farmak International aims to strengthen partnerships, respond more effectively to market needs, and further develop its portfolio in Mexico and Latin America. [press_quote] The Mexico team will focus on building partner relationships, supporting portfolio development, and establishing a strong platform for future growth in the region. [press_quote quote=2] About Farmak International Farmak International represents Farmak Group globally and supports the company’s international growth through partnerships, local market development, and commercial operations. With the opening of the Mexico office, Farmak Group now has 14 offices worldwide, while its products reach patients and healthcare systems in more than 60 countries. The company builds on Farmak’s 100-year heritage and strong expertise in complex generics, supported by capabilities across research and development, manufacturing, quality, regulatory affairs, supply chain, and commercial operations. Farmak Group operates three manufacturing plants, including EU GMP-certified facilities, supporting the development and supply of high-quality medicines to international markets. Farmak International Mexico office Mexico City, Mexico Phone: +52 55 91279146 Email: info@farmakinternational.mx